Home / Tenofovir Disoproxil and Emtricitabine / Canada
CA ATC J05AR03 · updated 2 Nov 2026
Tenofovir Disoproxil and Emtricitabine shortage in Canada
Is there a Tenofovir Disoproxil and Emtricitabine shortage in Canada?
Yes. As of 2 Nov 2026, 3 Tenofovir Disoproxil and Emtricitabine products are reported short in Canada, the first since 20 Jan 2025. The company estimate for the return is 20 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Austria, Belgium, Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | TEVA-EMTRICITABINE/TENOFOVIR (30) | TEVA CANADA LIMITED | 20 Jan 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL (30BT) | MYLAN PHARMACEUTICALS ULC | 16 May 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-EMTRICITABINE-TENOFOVIR (30 BTL) | APOTEX INC | 29 Sep 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.